Frigate Ventures »

Oncolytics Biotech shares owned by Frigate Ventures

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Frigate Ventures from 13F filings

Historical chart of Frigate Ventures investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Frigate Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Frigate Ventures

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.1M 3.8M 1.35
2023-09-30 $12M 5.3M 2.18

More positions owned by Frigate Ventures

Quantum Computing Equity (QUBT)
Strive Equity
Eightco Holdings Equity
Brera Holdings Equity
Match Group Equity (MTCH)
Lionsgate Studios Corp Equity (LION)
Nvidia Corp Equity (NVDA)
iShares U.S. Real Estate ETF Option Put Option (IYR)
Five9 Equity (FIVN)
Clear Channel Outdoor Holdings Equity (CCO)
Empery Digital Equity (EMPD)
Invesco QQQ Trust Series 1 Option Put Option (QQQ)
FutureCrest Acquisition Corp Equity Unit
AppLovin Corp Option Put Option (APP)
iShares MSCI Canada ETF Option Put Option (EWC)

View all positions for Frigate Ventures

Top funds holding Oncolytics Biotech

Citadel Advisors
Marshall Wace
Seeds Investor
Goldman Sachs Group
International Assets Investment Management
Franklin Resources
Royal Bank of Canada
Geode Capital Management
CIBC World Markets
LPL Financial
Headinvest
Badgley Phelps Wealth Managers
Ball & Co Wealth Management
SeaCrest Wealth Management
Federation des caisses Desjardins du Quebec

View all funds holding Oncolytics Biotech